Company intelligence / Profile preview
Regenerative Medicine Co.
Bangkok, Thailandregenmedasia.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Regenerative Medicine Co. has participated in six peer-reviewed clinical trials in Asia and Europe, notably pioneering the commercial use of stem cells for heart failure, including direct heart injection in congestive heart failure patients. Multiple products are used globally, some with FDA (international) approvals[3].
- Therapeutic areas
- CardiovascularOtherImmunology
- Modalities
- Stem cell therapyMesenchymal stem cell therapyExtracellular vesicle therapyBiologic
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Broad network with doctors, clinics, and distributors in 54 countriesRegulatory partnerships for product approvals[3]
Beyond the preview
Go deeper on Regenerative Medicine Co..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regenerative Medicine Co..